InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Janku Filip. Director active across 1 company, notably Monte Rosa Therapeutics, Inc.. Aggregated, 9 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €151k. History available since 23 February 2026. The latest transaction was disclosed on 23 February 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Janku Filip is a declarant linked to Monte Rosa Therapeutics, Inc. The 9 filings recorded cover the period from 2025-01-06 to 2026-06-30, and in the sampled recent filings, the total sell amount is EUR 151385, with Cession as the modal transaction nature.